We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Modern prostate cancer diagnostics reduce overdiagnosis – will they open up for population-based screening?
- Authors
Bratt, Ola; Lilja, Hans
- Abstract
Prostate cancer screening using a combination of risk-prediction, MRI, and targeted prostate biopsies (STHLM3-MRI): a prospective, population-based, randomised, open-label, non-inferiority trial. The göteborg prostate cancer screening 2 trial: a prospective, randomised, population-based prostate cancer screening trial with prostate-specific antigen testing followed by magnetic resonance imaging of the prostate. Clinical context: Population-based screening for prostate cancer with PSA tests and systematic prostate biopsies reduces cancer-specific mortality as much as screening for breast and colorectal cancer, but results in more harms in form of overdiagnosis and overtreatment.
- Subjects
PROSTATE cancer; MAGNETIC resonance imaging; OVERDIAGNOSIS; PROSTATE-specific antigen
- Publication
Scandinavian Journal of Urology, 2021, Vol 55, Issue 6, p491
- ISSN
2168-1805
- Publication type
Article
- DOI
10.1080/21681805.2021.1980608